Cavan O’Kane

Clinical Assistant Professor @RutgersU Internal Med Pharmacist @PrincetonHealth | PGY-2 Internal Med & PGY-1 @WVUMedicine | PharmD @TU_SP ‘19 | @LasalleExpl ‘15

[Cavan O’Kane @cokane_PharmD]

Tagging you so you don’t miss the $AEGIS led by @Vet_X0..
I putted 2,500 XRP in on https://t.co/gouSvDVUPw.

Could retire me if this moons 😂 You putting any bags on this?‍⁠‌‍​‌⁠

[Cavan O’Kane @cokane_PharmD]

Hey , was you able to get Loyaly Badge at https://t.co/CQTURSONnO?

I tried but got unlucky , was not eligible😕 , you are really lucky if you get one..

Oh , site will look better and smoother in pc btw, GL!​​‌‌‍​‌

[Cavan O’Kane @cokane_PharmD]

Hey , was you able to get Loyaly Badge at https://t.co/CQTURSONnO?

I tried but got unlucky , was not eligible😕 , you are really lucky if you get one..

Oh , site will look better and smoother in pc btw, GL!‌‍‌​​​​‍​‍⁠‍‌

[Cavan O’Kane @cokane_PharmD]

Hey , was you able to get Loyaly Badge at https://t.co/CQTURSONnO?

I tried but got unlucky , was not eligible😕 , you are really lucky if you get one..

Oh , site will look better and smoother in pc btw, GL!‍‍⁠​⁠‌‌‌

[LBaddour @LBaddour1]

Evaluation of Clinical Outcomes of Intravenous Drug Use-Related Infective Endocarditis in Buprenorphine-Treated Pat… https://t.co/iQ4dlFDUJO

🔥 Source control➡️"Addiction-focused intervention" during hospitalization.

[Pharmacotherapy @PharmacoJournal]

This study contributes to the growing body of evidence that DOACs may be effective and safe to use for the treatment of NVAF in patients with BMI ≥50 kg/m2. https://t.co/PTryXemuYU @WVUMedicine @accpcardprn